New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 7, 2014
15:27 EDTSYKMariel Therapeutics to acquire Stryker's BMP-7 assets
Mariel Therapeutics announced that it has entered into a definitive agreement to acquire Stryker Corporation's Bone Morphogenetic Protein-7, or BMP-7, assets for the potential treatment of osteoarthritis, chronic kidney disease and other organ fibrosis conditions, lupus, and obesity. Under the terms of the agreement, Mariel acquired the rights to over 450 issued and pending patents, Stryker's BMP-7-related clinical and research data, and the associated biologic materials. Stryker will have a right of first negotiation for commercial rights in the area of osteoarthritis. Financial terms of the transaction were not disclosed.
News For SYK From The Last 14 Days
Check below for free stories on SYK the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 12, 2014
10:00 EDTSYKOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
06:22 EDTSYKStryker upgraded to Buy from Hold at Needham
Subscribe for More Information
August 7, 2014
13:24 EDTSYKStryker upcoming analyst day may be catalyst for shares, says Argus
Argus believes Stryker is well positioned to post stronger sales and earnings in the second half of the year as new products launch and surgical volume rebounds. The firm thinks the company's analyst day on September 17 could be a catalyst for the shares and it maintains its Buy rating and $102 price target on the stock.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use